526 related articles for article (PubMed ID: 30886621)
1. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.
Chan BCL; Lam CWK; Tam LS; Wong CK
Front Immunol; 2019; 10():364. PubMed ID: 30886621
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
Cayrol C; Girard JP
Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
Front Immunol; 2018; 9():2004. PubMed ID: 30233590
[TBL] [Abstract][Full Text] [Related]
4. [Interleukin-33: from biology to potential treatments].
Schmitt P; Girard JP; Cayrol C
Med Sci (Paris); 2019 May; 35(5):440-451. PubMed ID: 31115327
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
Cayrol C; Girard JP
Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
Chen WY; Tsai TH; Yang JL; Li LC
Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
[TBL] [Abstract][Full Text] [Related]
7. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.
Lefrançais E; Duval A; Mirey E; Roga S; Espinosa E; Cayrol C; Girard JP
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15502-7. PubMed ID: 25313073
[TBL] [Abstract][Full Text] [Related]
8. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
[TBL] [Abstract][Full Text] [Related]
9. IL-33-Induced Atopic Dermatitis-Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with Basophils.
Imai Y; Yasuda K; Nagai M; Kusakabe M; Kubo M; Nakanishi K; Yamanishi K
J Invest Dermatol; 2019 Oct; 139(10):2185-2194.e3. PubMed ID: 31121178
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
11. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.
Cayrol C; Girard JP
Curr Opin Immunol; 2014 Dec; 31():31-7. PubMed ID: 25278425
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
Hong J; Kim S; Lin PC
J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
[TBL] [Abstract][Full Text] [Related]
13. Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury.
Chen WY; Li LC; Wu YH; Yang JL; Tzeng HT
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102434
[TBL] [Abstract][Full Text] [Related]
14. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
Front Immunol; 2020; 11():581445. PubMed ID: 33133101
[TBL] [Abstract][Full Text] [Related]
15. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
[TBL] [Abstract][Full Text] [Related]
16. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population.
Queiroz GA; Costa RS; Alcantara-Neves NM; Nunes de Oliveira Costa G; Barreto ML; Carneiro VL; Figueiredo CA
Int J Immunogenet; 2017 Apr; 44(2):51-61. PubMed ID: 28266165
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-33 in innate-type immune cells in allergy.
Nakae S; Morita H; Ohno T; Arae K; Matsumoto K; Saito H
Allergol Int; 2013 Mar; 62(1):13-20. PubMed ID: 23439054
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33 in atopic dermatitis.
Imai Y
J Dermatol Sci; 2019 Oct; 96(1):2-7. PubMed ID: 31455506
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33 and Behçet disease: Another cytokine among others.
Hamzaoui K; Bouali E; Hamzaoui A
Hum Immunol; 2015 May; 76(5):301-6. PubMed ID: 25814446
[TBL] [Abstract][Full Text] [Related]
20. The role of IL-33 and mast cells in allergy and inflammation.
Saluja R; Khan M; Church MK; Maurer M
Clin Transl Allergy; 2015; 5():33. PubMed ID: 26425339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
